Paliperidone

Jan 14, 2020

ANI Announces Launch of Paliperidone Extended-Release Tablets

Oct 30, 2019

Global Schizophrenia Drugs (Orals & Injectables) Market Insights, Trends and Forecasts, 2013-2018 & 2019-2023

Apr 09, 2019

Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia

Dec 13, 2018

Janssen Signs Results-Based Contract with Oklahoma Health Care Authority (OHCA) for its Long-Acting Injectable Schizophrenia Medicines

May 23, 2018

Invega Sustenna/Trinza (Paliperidone Palmitate; Johnson & Johnson) Drug Overview & Product Profiles 2018

May 03, 2018

Janssen to Present Data in Treatment-Resistant Depression, Schizophrenia, Health Economics and Outcomes and Population Health at American Psychiatric Association 2018 Meeting

Jan 03, 2018

Landmark Schizophrenia Data That Bring Hope in Breaking the Cycle of Hospitalization and Incarceration Receive FDA Approval for Inclusion in INVEGA SUSTENNA® (paliperidone palmitate) Label